QUESTIONSCHI’s Third Annual R & D Business Strategies
Venue: San Francisco
Location: San Francisco, California, United States
| Event Date/Time: Apr 20, 2005 | End Date/Time: Apr 22, 2005 |
Report as SpamDescription
The Pharmaceutical Strategy Series will present the Executive Track at the world renowned Molecular Medicine Tri-Conference in 2005. R&D Business Models will be one of five tracks at the 2,000-person event.
Topics to be covered include:
• In-Licensing and Out-Licensing Strategies
• Determining the Best Mix of In-Licensed verses Out-Licensed Products
• Implementing a Business Models that Best Meets a Company's Strategic Direction
• Determining the Best Mix of Late-Stage verse Early-Stage Compounds
• Best Practices for Creating Due Diligence Packages and Presenting to Big Pharma
• Creating a Successful Governance Structure
• How Pharmaceutical and Biotechnology Companies Can Differentiate Themselves as Ideal Partners
Topics to be covered include:
• In-Licensing and Out-Licensing Strategies
• Determining the Best Mix of In-Licensed verses Out-Licensed Products
• Implementing a Business Models that Best Meets a Company's Strategic Direction
• Determining the Best Mix of Late-Stage verse Early-Stage Compounds
• Best Practices for Creating Due Diligence Packages and Presenting to Big Pharma
• Creating a Successful Governance Structure
• How Pharmaceutical and Biotechnology Companies Can Differentiate Themselves as Ideal Partners
